NLRP3 inflammasome inhibition by the novel bispecific antibody inflamab inhibits atherosclerosis in apolipoprotein E-deficient mice

Author(s):
Delfos, L. (0000-0003-1018-191X); Depuydt, M.A.C. (0000-0002-7174-1952); Foks, A.C. (0000-0002-9747-3458); Bernabe Kleijn, M.N.A.; Kuiper, J.; Chemaly, M.; Peace, A.; McGilligan, V.; Bot, I. (0000-0002-1242-1959)
Published
2023
Publication type
Abstract
Date issued
2023-08-29
Language
English
Is part of
Atherosclerosis (2023), Vol. 379, no. Supplement 1, p. S2
hdl
1887/3720377
doi
10.1016/j.atherosclerosis.2023.06.885